Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta

The Truth About Closed-Loop Marketing
Pharma sales forces were out, well, in force for a two-day leadership summit put on by the Center for Business Intelligence this week in Philadelphia. As a newbie on the pharma reporting scene, I eagerly await these conference opportunities…especially the ones that deal with important sales management topics. This conference, in particular, presented sessions on just about every topic under the sales force sun—from cool new ways to reach physicians to interactive detailing and closed-loop promotion. In particular, I appreciated Matt Pammer’s presentation on examining the benefits and challenges of a rep-facilitated e-detailing program, and how it can complement a sales force strategy.
Pammer, executive director, IS client engagement for AstraZeneca, led a one-hour session that not only defined closed-loop marketing for me (finally!), but also provided a rundown of six keys for successful promotion:
1. Focus on digital content development. In other words, work closely with advertising agencies to identify what capabilities are appropriate for your brand. You don’t want anything in your ad taking away relative information from the consumer; there’s “no value to the discussion†if that occurs.
2. Speed the content-approval process. Ongoing education of key stakeholders is crucial. Pammer confidently admitted that AstraZeneca should have taken a more modular approach at the beginning.
3. Create and sustain marketing ownership. If you find problems flaring up in your marketing programs, take a step back and identify accountabilities.
4. Encourage sales engagement. To put it the Pammer way: “Tame the big brother fear.†It’s understandable that you can’t tell reps a specific way to sell. Instead, focus on usage and don’t short-circuit the training either. Training technology is reinforcement.
5. Integrate and focus on technologies. There is no such thing as an “insignificant†change with technology.
6. Practice organization-wide investment support. It’s not cheap but it’s measurable and will pave the way for future sales force technologies to follow. With the right hardware, CLP can do its job!
The future of closed-loop marketing is here. AstraZeneca has employed it for five years, and has reaped the benefits. By exploring trends with these capabilities in the marketplace, sales reps can produce similar results.